ASX-NSB Archives

ASX-NSB Healthcare Industrials

NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) Completes StemSmart Acquisition

ClubAI 27 June 2025 11:33 am

NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) completes acquisition of StemSmart technology, appoints new directors, and launches clinical program for Crohn’s disease treatment.

Latest News

Invictus Energy Ltd (ASX:IVZ) Updates on PPSA and National Project Status

NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) Completes StemSmart Acquisition

Celsius Resources Limited (ASX:CLA) Commences Engineering Activities for MCB Project

Sunrise Energy Metals Limited (ASX:SRL) Reports High-Grade Scandium Assays at Syerston

PYC Therapeutics (ASX:PYC) Advances PMS Drug Candidate to Clinical Trials

North Stawell Minerals (ASX:NSM) Announces $3.6M Capital Raising

Duxton Farms Ltd (ASX:DBF) Announces Strategic Merger and Special Dividend

Percheron Therapeutics (ASX:PER) Secures Worldwide License for HMBD-002

Aurizon Holdings Limited (ASX:AZJ) Announces FY2025 EBITDA and Leadership Restructuring

Yowie Group Ltd (ASX:YOW) Receives Interim Orders on Takeover Bid

Category: ASX-NSB

NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) Completes StemSmart Acquisition